create ppt slides Slide 1 — Title Rising Utilization of the Direct Anterior Approach in Total Hip Arthroplasty A review of registry, board-certification, and surgeon-survey data Slide 2 — Key Message The direct anterior approach (DAA) has risen sharply and now exceeds 50% of primary THA among U.S. surgeons. It has supplanted the posterior and lateral approaches as the most common technique — especially among early-career surgeons. The trend appears across registry data, board-certification data, and surgeon surveys. (Driesman and Yang, Arthroplasty, 2023; Nelson et al., J Arthroplasty, 2025) Slide 3 — Population & Market-Level Trends U.S.: Anterior-approach THA grew from an estimated 12% (2009) to 40% (2018), and most recent AAHKS polling places the DAA at >50% of primary THA. Ontario, Canada (population-based): Anterior approach rose from 8% (2015) to 12% (2017). Over 2015–2019 (30,098 THAs): 10% anterior, 70% lateral, 20% posterior — a lower baseline and slower adoption than the U.S. (Pincus et al., JAMA, 2020; Driesman and Yang, Arthroplasty, 2023) Slide 4 — Generational Shift: ABOS Board Data Among 35,068 THAs submitted to the American Board of Orthopaedic Surgery, 2022–2023: Approach Early-Career (Part II) Experienced (Recert) Direct anterior 69% 43% Posterior 26% 43% Direct lateral 2% 6% Other 2% 7% Early-career surgeons adopt the DAA at a markedly higher rate. (Nelson et al., J Arthroplasty, 2025) Slide 5 — Surgeon-Survey Data 2019 AAHKS survey (996 respondents): 56.2% currently perform the DAA; 76.1% of performers report increased patient market share. DAA performers had been in practice fewer years than non-performers (17.0 vs 20.9 years). Hip Society survey (high-volume academics): only 49.3% had ever used the DAA; 42.9% of former users abandoned it; only 22.5% believed evidence proves benefits outweigh risks. (Patel et al., J Arthroplasty, 2019; Woolson, Bone Joint J, 2020) Slide 6 — Caveats & Trade-offs Growth driven substantially by surgeon promotion and marketing, not high-level comparative evidence. Benefits: faster early rehabilitation, less muscle damage, lower dislocation rates. Trade-offs: Australian registry (122,345 THAs): higher early major revisions and femoral complications (periprosthetic fracture, femoral loosening). Ontario: higher 1-year major complication rate (2% vs 1%). Long-term RCT evidence of superiority remains limited. (Hallstrom and Hughes, JAMA, 2020; Hoskins et al., JBJS Am, 2020; Pincus et al., JAMA, 2020; Woolson, Bone Joint J, 2020) Slide 7 — Summary DAA utilization is rising rapidly and is now the dominant approach in the U.S., led by early-career surgeons. The shift is generational and partly market-driven. Clinical benefits are real but accompanied by early femoral complication and revision trade-offs; durable comparative evidence is still maturing.